BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37915905)

  • 1. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis.
    Miao J; Herrmann SM
    Clin Kidney J; 2023 Nov; 16(11):1834-1844. PubMed ID: 37915905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
    Tan HZ; Sprangers B
    Clin Kidney J; 2023 Nov; 16(11):1709-1713. PubMed ID: 37915924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
    Hakroush S; Kopp SB; Tampe D; Gersmann AK; Korsten P; Zeisberg M; Tampe B
    Front Immunol; 2020; 11():624547. PubMed ID: 33552089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
    Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
    Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
    Baker ML; Yamamoto Y; Perazella MA; Dizman N; Shirali AC; Hafez N; Weinstein J; Simonov M; Testani JM; Kluger HM; Cantley LG; Parikh CR; Wilson FP; Moledina DG
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35354588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study.
    GĂ©rard AO; Barbosa S; Parassol N; Andreani M; Merino D; Cremoni M; Laurain A; Pinel S; Bourneau-Martin D; Rocher F; Esnault VLM; Borchiellini D; Sicard A; Drici MD;
    Clin Kidney J; 2022 Oct; 15(10):1881-1887. PubMed ID: 36158153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease.
    Seethapathy H; Mistry K; Sise ME
    Immunol Rev; 2023 Sep; 318(1):61-69. PubMed ID: 37482912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis.
    Singh S; Long JP; Tchakarov A; Dong Y; Yee C; Lin JS
    JCI Insight; 2022 Dec; ():. PubMed ID: 36472921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management.
    Moturi K; Sharma H; Hashemi-Sadraei N
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor-Induced Kidney Injury.
    Abudayyeh A; Suo L; Lin H; Mamlouk O; Abdel-Wahab N; Tchakarov A
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
    Abdelrahim M; Mamlouk O; Lin H; Lin J; Page V; Abdel-Wahab N; Swan J; Selamet U; Yee C; Diab A; Suki W; Abudayyeh A
    Oncoimmunology; 2021 May; 10(1):1927313. PubMed ID: 34104543
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Prevention is better than cure': warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury.
    Belliere J; Sprangers B
    Clin Kidney J; 2022 Oct; 15(10):1803-1806. PubMed ID: 36158160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge.
    Miao J; Sise ME; Herrmann SM
    Front Nephrol; 2022; 2():1017921. PubMed ID: 37674988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes.
    Mohan A; Krisanapan P; Tangpanithandee S; Thongprayoon C; Kanduri SR; Cheungpasitporn W; Herrmann SM
    Am J Nephrol; 2024 Mar; ():. PubMed ID: 38471492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
    Sise ME; Seethapathy H; Reynolds KL
    Oncologist; 2019 Jun; 24(6):735-742. PubMed ID: 30902916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review.
    Xu LY; Zhao HY; Yu XJ; Wang JW; Zheng XZ; Jiang L; Wang SX; Liu G; Yang L
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause and immune checkpoint inhibitor-associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality.
    Chen JJ; Lee TH; Kuo G; Yen CL; Lee CC; Chang CH; Tu KH; Chen YC; Fang JT; Hung CC; Yang CW; Chou WC; Chi CC; Tu YK; Yu Yang H
    Clin Kidney J; 2024 Jan; 17(1):sfad292. PubMed ID: 38186874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors.
    Farooqui N; Zaidi M; Vaughan L; McKee TD; Ahsan E; Pavelko KD; Villasboas JC; Markovic S; Taner T; Leung N; Dong H; Alexander MP; Herrmann SM
    Kidney Int Rep; 2023 Mar; 8(3):628-641. PubMed ID: 36938084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors.
    Seethapathy H; Zhao S; Strohbehn IA; Lee M; Chute DF; Bates H; Molina GE; Zubiri L; Gupta S; Motwani S; Leaf DE; Sullivan RJ; Rahma O; Blumenthal KG; Villani AC; Reynolds KL; Sise ME
    Kidney Int Rep; 2020 Oct; 5(10):1700-1705. PubMed ID: 33102962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.